Supplementary Figure 2 from Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2<sup>−/−</sup>IL2Rγ<sup>null</sup> Immunodeficient Mice

crossref（2023）

引用 0|浏览8

暂无评分

摘要

Urelumab and Nivolumab bind to hCD137 and hPD-1 expressed on human T-lymphocytes engrafted in Rag2-/-IL2Rgcnull mice.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 2 from Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2&lt;sup&gt;−/−&lt;/sup&gt;IL2Rγ&lt;sup&gt;null&lt;/sup&gt; Immunodeficient Mice